Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics

[1]  Haiyan Hu,et al.  Coordinated regulation of BACH1 and mitochondrial metabolism through tumor-targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy , 2022, Acta pharmaceutica Sinica. B.

[2]  J. Sun,et al.  Prodrug Nanoassemblies Bridged by Mono-/Di-/Tri-Sulfide Bonds: Exploration is for Going Further , 2022, SSRN Electronic Journal.

[3]  Jie Feng,et al.  A covalent organic framework with a self-contained light source for photodynamic therapy. , 2022, Chemical communications.

[4]  Hongmin Liu,et al.  Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor , 2022, Acta pharmaceutica Sinica. B.

[5]  S. Yao,et al.  Stimulus-responsive self-assembled prodrugs in cancer therapy , 2022, Chemical science.

[6]  Fengting Lv,et al.  Bacteria-Mediated Intracellular Click Reaction for Drug Enrichment and Selective Apoptosis of Drug-Resistant Tumor Cells. , 2022, ACS applied materials & interfaces.

[7]  Zhuxian Zhou,et al.  Mucus Penetrating and Cell‐Binding Polyzwitterionic Micelles as Potent Oral Nanomedicine for Cancer Drug Delivery , 2022, Advanced materials.

[8]  Yueying Yang,et al.  Tumor-permeable smart liposomes by modulating the tumor microenvironment to improve the chemotherapy. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[9]  J. Gray,et al.  Targeted Nanoparticle for Co-delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis. , 2022, Small.

[10]  Yanbing Zhao,et al.  A Photosensitizer Discretely Loaded Nanoaggregate with Robust Photodynamic Effect for Local Treatment Triggers Systemic Antitumor Responses. , 2022, ACS nano.

[11]  Yongjun Wang,et al.  Emerging role of natural products in cancer immunotherapy , 2021, Acta pharmaceutica Sinica. B.

[12]  X. Jing,et al.  Intracellular Enzyme-Responsive Profluorophore and Prodrug Nanoparticles for Tumor-Specific Imaging and Precise Chemotherapy. , 2021, ACS applied materials & interfaces.

[13]  Zhigang Xie,et al.  Fluorinated paclitaxel prodrugs for potentiated stability and chemotherapy. , 2021, Journal of materials chemistry. B.

[14]  Yuzhu Hu,et al.  A folic acid-modified non-viral vector combines gene therapy with chemotherapy to reverse cancer chemotherapy resistance , 2021, Applied Materials Today.

[15]  P. Kesharwani,et al.  Taxanes loaded polymersomes as an emerging polymeric nanocarrier for cancer therapy , 2021, European Polymer Journal.

[16]  Youqing Shen,et al.  Nanomedicine from amphiphilizedprodrugs: concept and clinical translation. , 2021, Advanced drug delivery reviews.

[17]  A. Nokhodchi,et al.  Micro- and nanoformulations of paclitaxel based on micelles, liposomes, cubosomes, and lipid nanoparticles: recent advances and challenges. , 2021, Drug discovery today.

[18]  X. Jing,et al.  Engineering Paclitaxel Prodrug Nanoparticles via Redox-Activatable Linkage and Effective Carriers for Enhanced Chemotherapy. , 2021, ACS applied materials & interfaces.

[19]  M. Wan,et al.  Cascade‐Amplifying Synergistic Therapy for Intracranial Glioma via Endogenous Reactive Oxygen Species‐Triggered “All‐in‐One” Nanoplatform , 2021, Advanced Functional Materials.

[20]  Bingjun Sun,et al.  Small-Molecule Prodrug Nanoassemblies: An Emerging Nanoplatform for Anticancer Drug Delivery. , 2021, Small.

[21]  Hongbo Zhang,et al.  Nanoparticulation of Prodrug into Medicines for Cancer Therapy , 2021, Advanced science.

[22]  Zijian Zhou,et al.  Exquisite vesicular nanomedicine by paclitaxel mediated co-assembly with camptothecin prodrug. , 2021, Angewandte Chemie.

[23]  Yong Gan,et al.  Detachable Liposomes Combined Immunochemotherapy for Enhanced Triple-Negative Breast Cancer Treatment through Reprogramming of Tumor-Associated Macrophages. , 2021, Nano letters.

[24]  Bingjun Sun,et al.  Probing the fluorination effect on the self-assembly characteristics, in vivo fate and antitumor efficacy of paclitaxel prodrug nanoassemblies , 2021, Theranostics.

[25]  J. Sun,et al.  The length of disulfide bond-containing linkages impacts the oral absorption and antitumor activity of paclitaxel prodrug-loaded nanoemulsions. , 2021, Nanoscale.

[26]  Yahui Wu,et al.  An intracellular enzyme-responsive polymeric prodrug with synergistic effect of chemotherapy and two-photon photodynamic therapy , 2021 .

[27]  Jing Liu,et al.  High‐Contrast Fluorescence Diagnosis of Cancer Cells/Tissues Based on β‐Lapachone‐Triggered ROS Amplification Specific in Cancer Cells , 2021, Angewandte Chemie.

[28]  J. Sun,et al.  Emerging nanotaxanes for cancer therapy. , 2021, Biomaterials.

[29]  Meiwan Chen,et al.  Sequential Release of Pooled siRNAs and Paclitaxel by Aptamer-Functionalized Shell-Core Nanoparticles to Overcome Paclitaxel Resistance of Prostate Cancer. , 2021, ACS applied materials & interfaces.

[30]  D. Ding,et al.  Supramolecular Self‐Assembly‐Facilitated Aggregation of Tumor‐Specific Transmembrane Receptors for Signaling Activation and Converting Immunologically Cold to Hot Tumors , 2021, Advanced materials.

[31]  Hai-long Piao,et al.  The double-edged roles of ROS in cancer prevention and therapy , 2021, Theranostics.

[32]  Zhigang Xie,et al.  Merocyanine-paclitaxel conjugates for photothermal induced chemotherapy. , 2021, Journal of materials chemistry. B.

[33]  Zhongwei Gu,et al.  Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy , 2021, Theranostics.

[34]  Xiaoqi Dong,et al.  Biocompatible AIEgen/p-glycoprotein siRNA@reduction-sensitive paclitaxel polymeric prodrug nanoparticles for overcoming chemotherapy resistance in ovarian cancer , 2021, Theranostics.

[35]  Z. Qian,et al.  Co-Delivery of Paclitaxel and shMCL-1 by Folic Acid-Modified Nonviral Vector to Overcome Cancer Chemotherapy Resistance. , 2021, Small methods.

[36]  Yongbing Sun,et al.  Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy , 2021, Acta pharmaceutica Sinica. B.

[37]  I. Hyodo,et al.  Clinical implication of using up both fluoropyrimidine (FU) and paclitaxel (PTX) in patients with severe peritoneal metastases (SPM) of gastric cancer (GC). , 2021 .

[38]  Guofeng Zhang,et al.  Oxygen‐Evolving Manganese Ferrite Nanovesicles for Hypoxia‐Responsive Drug Delivery and Enhanced Cancer Chemoimmunotherapy , 2021, Advanced Functional Materials.

[39]  Wei He,et al.  Biological drug and drug delivery-mediated immunotherapy , 2020, Acta pharmaceutica Sinica. B.

[40]  Wei-ting Wang,et al.  Improved Antiglioblastoma Activity and BBB Permeability by Conjugation of Paclitaxel to a Cell‐Penetrative MMP‐2‐Cleavable Peptide , 2020, Advanced science.

[41]  Jin Sun,et al.  Pure redox-sensitive paclitaxel–maleimide prodrug nanoparticles: Endogenous albumin-induced size switching and improved antitumor efficiency , 2020, Acta pharmaceutica Sinica. B.

[42]  Z. Gu,et al.  Cathepsin B-responsive and gadolinium-labeled branched glycopolymer-PTX conjugate-derived nanotheranostics for cancer treatment , 2020, Acta pharmaceutica Sinica. B.

[43]  Zhigang Xie,et al.  Controlled synthesis of spindle-shaped terrylenediimide nanoparticles for enhanced tumor accumulation and treatment , 2021 .

[44]  D. Ding,et al.  HCPT-peptide prodrug with tumor microenvironment -responsive morphology transformable characteristic for boosted bladder tumor chemotherapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[45]  X. Jing,et al.  Comparison of Redox Responsiveness and Antitumor Capability of Paclitaxel Dimeric Nanoparticles with Different Linkers , 2020 .

[46]  J. Gallego-Jara,et al.  A Compressive Review about Taxol®: History and Future Challenges , 2020, Molecules.

[47]  Zhuang Liu,et al.  Recent progress of chemodynamic therapy-induced combination cancer therapy , 2020 .

[48]  Minhuan Lan,et al.  Advances and perspectives in carrier-free nanodrugs for cancer chemo-monotherapy and combination therapy. , 2020, Biomaterials.

[49]  Lipeng Qiu,et al.  Bioengineered Human Serum Albumin Fusion Protein as Target/Enzyme/pH Three-Stage Propulsive Drug Vehicle for Tumor Therapy. , 2020, ACS nano.

[50]  Jia Lv,et al.  Bifunctional and Bioreducible Dendrimer Bearing a Fluoroalkyl Tail for Efficient Protein Delivery Both In Vitro and In Vivo. , 2020, Nano letters.

[51]  Bingjun Sun,et al.  Trisulfide bond–mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity , 2020, Science Advances.

[52]  Bingjun Sun,et al.  Probing the Superiority of Diselenium Bond on Docetaxel Dimeric Prodrug Nanoassemblies: Small Roles Taking Big Responsibilities. , 2020, Small.

[53]  Gareth R. Williams,et al.  Carrier-free nanodrugs for safe and effective cancer treatment. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[54]  R. Haag,et al.  Tumor Microenvironment‐Activatable Nanoenzymes for Mechanical Remodeling of Extracellular Matrix and Enhanced Tumor Chemotherapy , 2020, Advanced Functional Materials.

[55]  Chunying Chen,et al.  Designing Hypoxia‐Responsive Nanotheranostic Agents for Tumor Imaging and Therapy , 2020, Advanced healthcare materials.

[56]  C. van Nostrum,et al.  Biotin-decorated all-HPMA polymeric micelles for paclitaxel delivery. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[57]  Zhigang Xie,et al.  Activatable paclitaxel prodrug in enhanced hypoxic microenvironment upon irradiation. , 2020, Angewandte Chemie.

[58]  Jingwei Shao,et al.  Efficient CRISPR/Cas9 gene-chemo synergistic cancer therapy via a stimuli-responsive chitosan-based nanocomplex elicits anti-tumorigenic pathway effect , 2020 .

[59]  Bingjun Sun,et al.  Dimeric prodrug-based nanomedicines for cancer therapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[60]  Zhigang Xie,et al.  Redox responsive paclitaxel dimer for programmed drug release and selectively killing cancer cells. , 2020, Journal of colloid and interface science.

[61]  Shutao Guo,et al.  Acid-sensitive PEGylated paclitaxel prodrug nanoparticles for cancer therapy: Effect of PEG length on antitumor efficacy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[62]  Haotian Zhang,et al.  An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition. , 2020, Biomaterials.

[63]  D. Yan,et al.  Carrier-Free Delivery of Precise Drug-Chemogene Conjugates for Synergistic Treatment of Drug-Resistant Cancer. , 2020, Angewandte Chemie.

[64]  Yongfei Li,et al.  Dual pH/ROS-Responsive Nanoplatform with Deep Tumor Penetration and Self-Amplified Drug Release for Enhancing Tumor Chemotherapeutic Efficacy. , 2020, Small.

[65]  Xing-jie Liang,et al.  Dually Enzyme- and Acid-Triggered Self-Immolative Ketal Glycoside Nanoparticles for Effective Cancer Prodrug Monotherapy. , 2020, Nano letters.

[66]  Y. Yamauchi,et al.  Self-assembly of block copolymers towards mesoporous materials for energy storage and conversion systems. , 2020, Chemical Society reviews.

[67]  B. Lin,et al.  Impeded Molecular Reorganization by Polyethylene Glycol Conjugation Revealed by X-ray Reflectivity and Diffraction Measurements. , 2020, Langmuir : the ACS journal of surfaces and colloids.

[68]  A. Pich,et al.  Dual-Temperature-Responsive Microgels from a Zwitterionic Functional Graft Copolymer with Superior Protein Repelling Property. , 2020, ACS macro letters.

[69]  Zhuxian Zhou,et al.  Assemblies of indocyanine green and chemotherapeutic drug to cure established tumors by synergistic chemo-photo therapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[70]  P. Král,et al.  Tuning of the Aggregation Behavior of Fluorinated Polymeric Nanoparticles for Improved Therapeutic Efficacy. , 2020, ACS nano.

[71]  A. Chen,et al.  Synergistic chemotherapy for breast cancer and breast cancer brain metastases via paclitaxel-loaded oleanolic acid nanoparticles. , 2020, Molecular Pharmaceutics.

[72]  A. Chilkoti,et al.  Genetically encoded stealth nanoparticles of a zwitterionic polypeptide-paclitaxel conjugate have a wider therapeutic window than Abraxane in multiple tumor models. , 2020, Nano letters.

[73]  Zhuxian Zhou,et al.  Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[74]  W. Chiu,et al.  Ultra-thermostable RNA nanoparticles for solubilizing and high-yield loading of paclitaxel for breast cancer therapy , 2020, Nature Communications.

[75]  Yingli Wang,et al.  Remote loading paclitaxel–doxorubicin prodrug into liposomes for cancer combination therapy , 2020, Acta pharmaceutica Sinica. B.

[76]  Lichen Yin,et al.  Fluorinated α-Helical Polypeptides Synchronize Mucus Permeation and Cell Penetration toward Highly Efficient Pulmonary siRNA Delivery against Acute Lung Injury. , 2020, Nano letters.

[77]  Mohammad Kazemi Ashtiani,et al.  Co-delivery of minocycline and paclitaxel from injectable hydrogel for treatment of spinal cord injury. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[78]  Z. Gu,et al.  A Nanostrategy for Efficient Imaging‐Guided Antitumor Therapy through a Stimuli‐Responsive Branched Polymeric Prodrug , 2020, Advanced science.

[79]  Yong Wang,et al.  Codelivery of Anti-PD-1 Antibody and Paclitaxel with Matrix Metalloproteinase and pH Dual-Sensitive Micelles for Enhanced Tumor Chemoimmunotherapy. , 2020, Small.

[80]  C. Yuan,et al.  Enhanced antitumor efficacy and imaging application of photosensitizer-formulated Paclitaxel. , 2020, ACS applied materials & interfaces.

[81]  Jun Wu,et al.  Nanodrug Carrier Based on Poly(Ursolic Acid) with Self‐Anticancer Activity against Colorectal Cancer , 2019, Advanced Functional Materials.

[82]  L. Belvisi,et al.  Fast Cyclization of a Proline-Derived Self-Immolative Spacer Improves the Efficacy of Carbamate Prodrugs. , 2019, Angewandte Chemie.

[83]  J. Jokerst,et al.  Photoacoustic Imaging Quantifies Drug Release from Nanocarriers via Redox Chemistry of Dye-Labeled Cargo. , 2019, Angewandte Chemie.

[84]  Yaping Li,et al.  Enhancing Triple Negative Breast Cancer Immunotherapy by ICG‐Templated Self‐Assembly of Paclitaxel Nanoparticles , 2019, Advanced Functional Materials.

[85]  Y. Kondoh,et al.  Weekly nab-PTX and weekly PTX for relapsed small cell lung cancer , 2019, Annals of Oncology.

[86]  M. Blake.  I.4 Advances in Radiotherapy and Radiotherapy Innovations , 2019, Journal of Thoracic Oncology.

[87]  Leilei Shi,et al.  A Paclitaxel-Based Mucoadhesive Nanogel with Multivalent Interactions for Cervical Cancer Therapy. , 2019, Small.

[88]  J. Ahn,et al.  Phase II study of DHP107 oral paclitaxel in first-line, HER2 negative recurrent/metastatic breast cancer (OPTIMAL study, NCT03315364) , 2019, Annals of Oncology.

[89]  Yuan Yuan,et al.  Impact of Antifouling PEG Layer on the Performance of Functional Peptides in Regulating Cell Behaviors. , 2019, Journal of the American Chemical Society.

[90]  Manal A. Elsheikh,et al.  Current strategies for different paclitaxel-loaded Nano-delivery Systems towards therapeutic applications for ovarian carcinoma: A review article. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[91]  Ahmedin Jemal,et al.  Cancer treatment and survivorship statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[92]  Peng Xue,et al.  Hydrophobic drug self-delivery systems as a versatile nanoplatform for cancer therapy: A review. , 2019, Colloids and surfaces. B, Biointerfaces.

[93]  Jingqing Yang,et al.  Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death , 2019, Nature Communications.

[94]  Pengjian Zuo,et al.  Single small molecule-assembled nanoparticles mediate efficient oral drug delivery , 2019, Nano Research.

[95]  Bingjun Sun,et al.  Redox dual-responsive paclitaxel-doxorubicin heterodimeric prodrug self-delivery nanoaggregates for more effective breast cancer synergistic combination chemotherapy. , 2019, Nanomedicine : nanotechnology, biology, and medicine.

[96]  Xiaoquan Yang,et al.  A Simple Glutathione-Responsive Turn-on Theranostic Nanoparticle for Dual-Modal Imaging and Chemo-Photothermal Combination Therapy. , 2019, Nano letters.

[97]  Bingjun Sun,et al.  Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy , 2019, Nature Communications.

[98]  Niel M. Henriksen,et al.  Antitumor Activity of 1,18-Octadecanedioic Acid-Paclitaxel Complexed with Human Serum Albumin , 2019, Journal of the American Chemical Society.

[99]  M. Kida,et al.  A clinical trial to assess the feasibility and efficacy of nab-paclitaxel plus gemcitabine for elderly patients with unresectable advanced pancreatic cancer , 2019, International Journal of Clinical Oncology.

[100]  Bingjun Sun,et al.  Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy. , 2019, Acta biomaterialia.

[101]  Jun Yu Li,et al.  Tetramethylpyrazine Enhances the Antitumor Effect of Paclitaxel by Inhibiting Angiogenesis and Inducing Apoptosis , 2019, Front. Pharmacol..

[102]  Weijie Zhang,et al.  Paclitaxel-Promoted Supramolecular Polymerization of Peptide Conjugates. , 2019, Journal of the American Chemical Society.

[103]  Maarten M. J. Smulders,et al.  Steering the Self‐Assembly Outcome of a Single NDI Monomer into Three Morphologically Distinct Supramolecular Assemblies, with Concomitant Change in Supramolecular Polymerization Mechanism , 2019, Advanced science.

[104]  Kanyi Pu,et al.  Organic Photodynamic Nanoinhibitor for Synergistic Cancer Therapy. , 2019, Angewandte Chemie.

[105]  Wei Cheng,et al.  NIR-Light-Activated Combination Therapy with a Precise Ratio of Photosensitizer and Prodrug Using a Host-Guest Strategy. , 2019, Angewandte Chemie.

[106]  X. Shuai,et al.  Core-Shell Distinct Nanodrug Showing On-Demand Sequential Drug Release To Act on Multiple Cell Types for Synergistic Anticancer Therapy. , 2019, ACS nano.

[107]  Qin Chen,et al.  Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[108]  Rami W. Chakroun,et al.  Fine-Tuning the Linear Release Rate of Paclitaxel-Bearing Supramolecular Filament Hydrogels through Molecular Engineering. , 2019, ACS nano.

[109]  Haotian Zhang,et al.  Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer. , 2019, ACS applied materials & interfaces.

[110]  X. Jing,et al.  Albumin-bound paclitaxel dimeric prodrug nanoparticles with tumor redox heterogeneity-triggered drug release for synergistic photothermal/chemotherapy , 2019, Nano Research.

[111]  Yuanyuan Guo,et al.  Stressing the Role of DNA as a Drug Carrier: Synthesis of DNA–Drug Conjugates through Grafting Chemotherapeutics onto Phosphorothioate Oligonucleotides , 2019, Advanced materials.

[112]  A. Kros,et al.  DePEGylation strategies to increase cancer nanomedicine efficacy. , 2019, Nanoscale horizons.

[113]  D. Ding,et al.  A Noncovalent Fluorescence Turn-on Strategy for Hypoxia Imaging. , 2019, Angewandte Chemie.

[114]  Chenping Wang,et al.  Facile Engineering of Indomethacin-Induced Paclitaxel Nanocrystal Aggregates as Carrier-Free Nanomedicine with Improved Synergetic Antitumor Activity. , 2019, ACS applied materials & interfaces.

[115]  Xiao Lei Chen,et al.  Bioengineered Nanocage from HBc Protein for Combination Cancer Immunotherapy. , 2019, Nano letters.

[116]  Eric P. Winer,et al.  Breast Cancer Treatment: A Review , 2019, JAMA.

[117]  Chen Jiang,et al.  Activated Platelets‐Targeting Micelles with Controlled Drug Release for Effective Treatment of Primary and Metastatic Triple Negative Breast Cancer , 2019, Advanced Functional Materials.

[118]  Chun‐Sing Lee,et al.  Green Mass Production of Pure Nanodrugs via an Ice-Template-Assisted Strategy. , 2018, Nano letters.

[119]  Huile Gao,et al.  Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment , 2018, Acta pharmaceutica Sinica. B.

[120]  N. Garti,et al.  Basic principles of drug delivery systems - the case of paclitaxel. , 2019, Advances in colloid and interface science.

[121]  Chao Wu,et al.  Pure paclitaxel nanoparticles: preparation, characterization, and antitumor effect for human liver cancer SMMC-7721 cells , 2018, International journal of nanomedicine.

[122]  Shuying Wang,et al.  Biological Stimulus‐Driven Assembly/Disassembly of Functional Nanoparticles for Targeted Delivery, Controlled Activation, and Bioelimination , 2018, Advanced healthcare materials.

[123]  Emily A. Smith,et al.  A Photoactivatable BODIPY Probe for Localization-Based Super-Resolution Cellular Imaging. , 2018, Angewandte Chemie.

[124]  Bingjun Sun,et al.  Precisely albumin‐hitchhiking tumor cell‐activated reduction/oxidation‐responsive docetaxel prodrugs for the hyperselective treatment of breast cancer , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[125]  Jonathan F. Lovell,et al.  Current taxane formulations and emerging cabazitaxel delivery systems , 2018, Nano Research.

[126]  D. Braguer,et al.  Delaying Anticancer Drug Delivery by Self-Assembly and Branching Effects of Minimalist Dendron-Drug Conjugates. , 2018, Chemistry.

[127]  Qiang Zhang,et al.  The effect of linkers on the self‐assembling and anti‐tumor efficacy of disulfide‐linked doxorubicin drug‐drug conjugate nanoparticles , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[128]  L. Wan,et al.  Biodegradable, Hydrogen Peroxide, and Glutathione Dual Responsive Nanoparticles for Potential Programmable Paclitaxel Release. , 2018, Journal of the American Chemical Society.

[129]  Qin Chen,et al.  Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy. , 2018, Nano letters.

[130]  Peixuan Guo,et al.  RNA‐based micelles: A novel platform for paclitaxel loading and delivery , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[131]  N. Meanwell,et al.  The expanding role of prodrugs in contemporary drug design and development , 2018, Nature Reviews Drug Discovery.

[132]  Yanli Zhao,et al.  Supramolecular Vesicles for Stimulus‐Responsive Drug Delivery , 2018 .

[133]  Y. Yeo,et al.  A Comparative In Vivo Study of Albumin-Coated Paclitaxel Nanocrystals and Abraxane. , 2018, Small.

[134]  Wenjuan Ma,et al.  Overcoming drug-resistant lung cancer by paclitaxel loaded tetrahedral DNA nanostructures. , 2018, Nanoscale.

[135]  Xiao‐Yu Hu,et al.  Highly Efficient Artificial Light-Harvesting Systems Constructed in Aqueous Solution Based on Supramolecular Self-Assembly. , 2018, Angewandte Chemie.

[136]  G. Bazan,et al.  Cross‐Linking of Thiolated Paclitaxel–Oligo(p‐phenylene vinylene) Conjugates Aggregates inside Tumor Cells Leads to “Chemical Locks” That Increase Drug Efficacy , 2018, Advanced materials.

[137]  Xiaoyuan Chen,et al.  A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy , 2018, Theranostics.

[138]  X. Jing,et al.  Light-Activatable Red Blood Cell Membrane-Camouflaged Dimeric Prodrug Nanoparticles for Synergistic Photodynamic/Chemotherapy. , 2018, ACS nano.

[139]  Yen-Nan Lin,et al.  Chemical Design of Both a Glutathione-Sensitive Dimeric Drug Guest and a Glucose-Derived Nanocarrier Host to Achieve Enhanced Osteosarcoma Lung Metastatic Anticancer Selectivity. , 2018, Journal of the American Chemical Society.

[140]  Jianxu Zhang,et al.  Tailoring the morphology of AIEgen fluorescent nanoparticles for optimal cellular uptake and imaging efficacy , 2018, Chemical science.

[141]  Zhonggui He,et al.  Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy , 2018, Drug delivery.

[142]  Chen Jiang,et al.  Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma , 2017, Acta pharmaceutica Sinica. B.

[143]  S. Khan,et al.  Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer , 2017, Acta pharmaceutica Sinica. B.

[144]  D. Rubello,et al.  Paclitaxel-loaded folate-coated long circulating and pH-sensitive liposomes as a potential drug delivery system: A biodistribution study. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[145]  Feihu Wang,et al.  Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy. , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[146]  Yan Guo,et al.  A Small Molecule Nanodrug by Self-Assembly of Dual Anticancer Drugs and Photosensitizer for Synergistic near-Infrared Cancer Theranostics. , 2017, ACS applied materials & interfaces.

[147]  G. Storm,et al.  The battle of “nano” paclitaxel , 2017, Advanced drug delivery reviews.

[148]  Zhigang Xie,et al.  Nanoprodrug of retinoic acid-modified paclitaxel. , 2017, Organic & biomolecular chemistry.

[149]  Xiaojuan He,et al.  A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer , 2017, Nature Communications.

[150]  Honggang Cui,et al.  Self-assembling prodrugs. , 2017, Chemical Society reviews.

[151]  Bingjun Sun,et al.  Chemotherapy agent‐unsaturated fatty acid prodrugs and prodrug‐nanoplatforms for cancer chemotherapy , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[152]  Jianbin Tang,et al.  A Tumor‐Specific Cascade Amplification Drug Release Nanoparticle for Overcoming Multidrug Resistance in Cancers , 2017, Advanced materials.

[153]  Jingwei Shao,et al.  Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex. , 2017, Biomaterials.

[154]  Rationalizing combination therapies , 2017, Nature Medicine.

[155]  Bingjun Sun,et al.  Reduction-sensitive Paclitaxel Prodrug Self-assembled Nanoparticles with Tetrandrine Effectively Promote Synergistic Therapy Against Drug-sensitive and Multidrug-resistant Breast Cancer. , 2017, Molecular pharmaceutics.

[156]  Jarkko Rautio,et al.  Prodrugs in medicinal chemistry and enzyme prodrug therapies , 2017, Advanced drug delivery reviews.

[157]  A. Annala,et al.  Cell‐mediated enzyme prodrug cancer therapies , 2017, Advanced drug delivery reviews.

[158]  Mingshi Yang,et al.  Advances in combination therapy of lung cancer: Rationales, delivery technologies and dosage regimens , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[159]  A. Studer,et al.  Reversible Stabilization of Vesicles: Redox-Responsive Polymer Nanocontainers for Intracellular Delivery. , 2017, Angewandte Chemie.

[160]  Zhigang Xie,et al.  Glutathione-responsive paclitaxel dimer nanovesicles with high drug content. , 2017, Biomaterials science.

[161]  D. Chiappetta,et al.  Paclitaxel: What has been done and the challenges remain ahead. , 2017, International journal of pharmaceutics.

[162]  X. Jing,et al.  Paclitaxel dimers assembling nanomedicines for treatment of cervix carcinoma , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[163]  A. Das,et al.  Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition , 2017, Molecules.

[164]  B. Peterson,et al.  Synthesis of a Fluorescent Analogue of Paclitaxel That Selectively Binds Microtubules and Sensitively Detects Efflux by P-Glycoprotein. , 2017, Angewandte Chemie.

[165]  Yitao Wang,et al.  Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells , 2017, Scientific Reports.

[166]  Youqing Shen,et al.  Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization , 2017, Advanced materials.

[167]  A. Sureda,et al.  Oleanolic Acid Alters Multiple Cell Signaling Pathways: Implication in Cancer Prevention and Therapy , 2017, International journal of molecular sciences.

[168]  D. Citrin.  Recent Developments in Radiotherapy. , 2017, The New England journal of medicine.

[169]  Youqing Shen,et al.  Targeted Co-delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer. , 2017, Small.

[170]  Bingjun Sun,et al.  Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug as Potent Chemotherapeutic Nanomedicine. , 2016, Small.

[171]  Ting Zhong,et al.  A self-assembling nanomedicine of conjugated linoleic acid-paclitaxel conjugate (CLA-PTX) with higher drug loading and carrier-free characteristic , 2016, Scientific Reports.

[172]  S. van Calenbergh,et al.  Well-Defined Polymer-Paclitaxel Prodrugs by a Grafting-from-Drug Approach. , 2016, Angewandte Chemie.

[173]  Charles Schmidt.  Immunotherapy: Controlled attack , 2016, Nature.

[174]  Zhirong Zhang,et al.  A New Concept of Enhancing Immuno-Chemotherapeutic Effects Against B16F10 Tumor via Systemic Administration by Taking Advantages of the Limitation of EPR Effect , 2016, Theranostics.

[175]  Zhonggui He,et al.  Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy. , 2016, Nano letters.

[176]  Zhen Zhang,et al.  A Phase II Study of Concurrent Chemoradiotherapy With Paclitaxel and Cisplatin for Inoperable Esophageal Squamous Cell Carcinoma , 2016, American journal of clinical oncology.

[177]  G. Kwon,et al.  Oligo(lactic acid)n-Paclitaxel Prodrugs for Poly(ethylene glycol)-block-poly(lactic acid) Micelles: Loading, Release, and Backbiting Conversion for Anticancer Activity. , 2016, Journal of the American Chemical Society.

[178]  L. Paz-Ares,et al.  Current Challenges in Cancer Treatment. , 2016, Clinical therapeutics.

[179]  K. Thurecht,et al.  Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date , 2016, Pharmaceutical Research.

[180]  Yuta Koda,et al.  Multimode Self-Folding Polymers via Reversible and Thermoresponsive Self-Assembly of Amphiphilic/Fluorous Random Copolymers , 2016 .

[181]  X. Jing,et al.  Redox-Hypersensitive Organic Nanoparticles for Selective Treatment of Cancer Cells , 2016 .

[182]  Jong Seung Kim,et al.  Mitochondria-targeted aggregation induced emission theranostics: crucial importance of in situ activation† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c6sc02236g , 2016, Chemical science.

[183]  Ning Zhang,et al.  Interfacial Cohesion and Assembly of Bioadhesive Molecules for Design of Long-Term Stable Hydrophobic Nanodrugs toward Effective Anticancer Therapy. , 2016, ACS nano.

[184]  Ronit Vogt Sionov,et al.  Indomethacin sensitizes resistant transformed cells to macrophage cytotoxicity , 2016, Immunology letters.

[185]  H. Schneider,et al.  Experimental Binding Energies in Supramolecular Complexes. , 2016, Chemical reviews.

[186]  Ravi Kumar,et al.  Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II/III study , 2016, Breast Cancer Research and Treatment.

[187]  X. Jing,et al.  Small molecular nanomedicines made from a camptothecin dimer containing a disulfide bond , 2015 .

[188]  Alejandro Sosnik,et al.  Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers. , 2015, Advances in colloid and interface science.

[189]  Ran Tian,et al.  Drug delivery with nanospherical supramolecular cell penetrating peptide-taxol conjugates containing a high drug loading. , 2015, Journal of colloid and interface science.

[190]  J. Andersen,et al.  The role of albumin receptors in regulation of albumin homeostasis: Implications for drug delivery. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[191]  J. Niu,et al.  Albumin-bound paclitaxel in solid tumors: clinical development and future directions , 2015, Drug design, development and therapy.

[192]  I. Vergote,et al.  Randomized phase III study comparing paclical-carboplatin with paclitaxel-carboplatin in patients with recurrent platinum-sensitive epithelial ovarian cancer. , 2015 .

[193]  F. Uckun,et al.  Dimeric drug polymeric nanoparticles with exceptionally high drug loading and quantitative loading efficiency. , 2015, Journal of the American Chemical Society.

[194]  Shengfu Chen,et al.  The fabrication of superlow protein absorption zwitterionic coating by electrochemically mediated atom transfer radical polymerization and its application. , 2015, Acta biomaterialia.

[195]  Chun‐Sing Lee,et al.  Preparation and size control of sub-100 nm pure nanodrugs. , 2015, Nano letters.

[196]  Youqing Shen,et al.  Integration of Nanoassembly Functions for an Effective Delivery Cascade for Cancer Drugs , 2014, Advanced materials.

[197]  F. Liu,et al.  Disulfide Bond Bridge Insertion Turns Hydrophobic Anticancer Prodrugs into Self-Assembled Nanomedicines , 2014, Nano letters.

[198]  Sarah A Heerboth,et al.  Drug Resistance in Cancer: An Overview , 2014, Cancers.

[199]  L. Gravitz.  Cancer immunotherapy , 2013, Nature.

[200]  Julie Mougin,et al.  Novel isoprenoyl nanoassembled prodrug for paclitaxel delivery. , 2013, Bioconjugate chemistry.

[201]  P. Johnston,et al.  Cancer drug resistance: an evolving paradigm , 2013, Nature Reviews Cancer.

[202]  M. Junttila,et al.  Influence of tumour micro-environment heterogeneity on therapeutic response , 2013, Nature.

[203]  G. Bhattacharyya,et al.  Clinical and economic implications of the use of nanoparticle paclitaxel (Nanoxel) in India. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[204]  J. Siepmann,et al.  Mathematical modeling of drug dissolution. , 2013, International journal of pharmaceutics.

[205]  H. Cui,et al.  Supramolecular filaments containing a fixed 41% paclitaxel loading. , 2013, Chemical communications.

[206]  S. H. van der Burg,et al.  Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment. , 2013, Cancer research.

[207]  Zhuang Liu,et al.  Carrier-free, functionalized pure drug nanorods as a novel cancer-targeted drug delivery platform , 2013, Nanotechnology.

[208]  Matthew L. Brown,et al.  Profluorogenic reductase substrate for rapid, selective, and sensitive visualization and detection of human cancer cells that overexpress NQO1. , 2013, Journal of the American Chemical Society.

[209]  Pingchaun Li,et al.  Ursolic acid induces ER stress response to activate ASK1-JNK signaling and induce apoptosis in human bladder cancer T24 cells. , 2013, Cellular signalling.

[210]  P. Couvreur,et al.  Improving the Antitumor Activity of Squalenoyl‐Paclitaxel Conjugate Nanoassemblies by Manipulating the Linker between Paclitaxel and Squalene , 2013, Advanced healthcare materials.

[211]  Xin-en Huang,et al.  Clinical comparison between paclitaxel liposome (Lipusu®) and paclitaxel for treatment of patients with metastatic gastric cancer. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[212]  Jaroslav Turánek,et al.  Liposomal paclitaxel formulations. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[213]  Yukio Fujiwara,et al.  Oleanolic acid inhibits macrophage differentiation into the M2 phenotype and glioblastoma cell proliferation by suppressing the activation of STAT3. , 2011, Oncology reports.

[214]  F. Dosio,et al.  Targeted Taxane Delivery Systems: Recent Advances , 2011 .

[215]  P. Clancy.  Nanoparticles: self-assembly finds its own limits. , 2011, Nature nanotechnology.

[216]  P. Couvreur,et al.  Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics. , 2011, ACS nano.

[217]  I. Manners,et al.  Monodisperse cylindrical micelles by crystallization-driven living self-assembly. , 2010, Nature chemistry.

[218]  P. Ang,et al.  Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[219]  Christopher E. Wilmer,et al.  Nanoscale forces and their uses in self-assembly. , 2009, Small.

[220]  Soo-Chang Song,et al.  Thermosensitive poly(organophosphazene)-paclitaxel conjugate gels for antitumor applications. , 2009, Biomaterials.

[221]  Edward Chu,et al.  A history of cancer chemotherapy. , 2008, Cancer research.

[222]  D. O’Carroll,et al.  Template Synthesis of Highly Oriented Polyfluorene Nanotube Arrays , 2008 .

[223]  Mitchell A. Winnik,et al.  Cylindrical Block Copolymer Micelles and Co-Micelles of Controlled Length and Architecture , 2007, Science.

[224]  J. Minna,et al.  An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by β-lapachone , 2007, Proceedings of the National Academy of Sciences.

[225]  Karl-Heinz Altmann,et al.  Anticancer drugs from nature--natural products as a unique source of new microtubule-stabilizing agents. , 2007, Natural product reports.

[226]  Glen S. Kwon,et al.  Paclitaxel Prodrugs with Sustained Release and High Solubility in Poly(ethylene glycol)-b-poly(ε-caprolactone) Micelle Nanocarriers: Pharmacokinetic Disposition, Tolerability, and Cytotoxicity , 2007, Pharmaceutical Research.

[227]  P. Johnston,et al.  Molecular mechanisms of drug resistance , 2005, The Journal of pathology.

[228]  B. Chabner,et al.  Chemotherapy and the war on cancer , 2005, Nature Reviews Cancer.

[229]  Tae-You Kim,et al.  Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies , 2004, Clinical Cancer Research.

[230]  Nicholas H Oberlies,et al.  Camptothecin and taxol: historic achievements in natural products research. , 2004, Journal of natural products.

[231]  P. Tyre.  Combination therapy. , 2004, Newsweek.

[232]  G. Grasselli,et al.  Clinical and pharmacologic study of the epirubicin and paclitaxel combination in women with metastatic breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[233]  P. Vaupel,et al.  Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.

[234]  E. W. Meijer,et al.  Reversible polymers formed from self-complementary monomers using quadruple hydrogen bonding. , 1997, Science.

[235]  A. McPhail,et al.  Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. , 1971, Journal of the American Chemical Society.